(Q45394430)

English

Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes

scientific article published on 21 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis B virus

1 reference

based on heuristic

Pierre-François Pradat

3

object named as

Pierre Pradat

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Fadi Saade

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Thierry Buronfosse

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Fabien Abdul

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Lucyna Cova

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

21 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

5159-5164

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Stealth and cunning: hepatitis B and hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Bovine interleukins 2 and 4 expressed in recombinant bovine herpesvirus 1 are biologically active secreted glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Co-administration of IL-2 enhances antigen-specific immune responses following vaccination with DNA encoding the glycoprotein E2 of bovine viral diarrhoea virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Early life humoral response of ducks to DNA immunization against hepadnavirus large envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Rise in gamma interferon expression during resolution of duck hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Cloning, in vitro expression and bioactivity of duck interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Comparison of biological activities of natural and recombinant chicken interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

based on heuristic

inferred from DOI database lookup

Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.086

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.03.086

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45394430&oldid=2076532023"